Stroke and CPAP Outcome Study 3 Randomized Controlled Trial
NCT: NCT06722755 · RECRUITING
Brief Summary
The SCOUTS 3 study aims to test the effectiveness of an intensive CPAP (Continuous Positive Airway Pressure) therapy support program compared to usual care in stroke patients with obstructive sleep apnea (OSA) during inpatient rehabilitation (IPR). The study is a multicenter randomized controlled trial (RCT) involving recruitment of about 250 participants across two institutions and randomization of about 200 participants. It compares an intensive support (IS) program for CPAP use with standard support (SS) to evaluate the effectiveness of the IS intervention in increasing CPAP usage during and after stroke rehabilitation. The Intensive Support (IS) group will receive a multicomponent intensive behavioral adherence program, which includes a CPAP technical support intervention, Motivational Enhancement Therapy (MET), and a Mobile Health intervention. Outcomes measured include CPAP adherence as measured by average nightly use in minutes between randomization and 3 months and the modified Rankin Scale (mRS-9Q) to evaluate stroke recovery.
Frequently Asked Questions
What is Stroke and CPAP Outcome Study 3 Randomized Controlled Trial?
Stroke and CPAP Outcome Study 3 Randomized Controlled Trial is a clinical trial registered under NCT06722755. Current status: RECRUITING.
What is the status of NCT06722755?
The current status of NCT06722755 (Stroke and CPAP Outcome Study 3 Randomized Controlled Trial) is: RECRUITING.
When did Stroke and CPAP Outcome Study 3 Randomized Controlled Trial start?
Stroke and CPAP Outcome Study 3 Randomized Controlled Trial started on 2025-01-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.